|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hypercholesterolemia and hypertriglyceridemia- greatest cardiac risk in subjects with high apoB/apoA - I levels 显示文摘 | Walldius G Aastveit A Jungner I | 2004 | Int Congr Ser2004，1262，12： | 1 |
| 2 | Is there a better marker of cardiovascular risk factor than LDL cholesterol apolipo proteins B and A-i-new risk factors and targets for therapy显示文摘 | Walldius G Jungner I | 2007 | Nutr Metab Cardiovasc Dis2007，17，8： | 1 |
| 3 | The apo B/apo A-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipidlowering therapy-a review of the evidence显示文摘 | Walldius G Jungner I | 2006 | J Intern Med2006，259，5： | 1 |
| 4 | Apolipoprotein B and apolipoprotein A- I risk indicators of coronary heart disease and targets for lipid-modifying therapy显示文摘 | Walldius G Jungner I | 2004 | J Intern Med2004，255，2： | 1 |
| 5 | Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary, heart disease and targets for lipid-modifying therapy显示文摘 | WALLDIUS G JUNGNER I | 2004 | J Intern Med2004，255，2： | 1 |
| 6 | High apelipoprotein B, low apeli- peprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study) : a prospective study 显示文摘 | Walldius G Jungner I Holme I | 2001 | Lancet2001，358，9298： | 1 |
| 7 | High apoli poprotein B, low apolipoprotein A I , and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study显示文摘 | WALLDIUS G JUNGNER I HOLME I | 2001 | The Lancet2001，358，9298： | 1 |
| 8 | Apolipoprotein B and apolipoprotein A-I : risk indicators of coronary heart disease and targets for lipid-modifying therapy显示文摘 | Walldius G Jungner I | 2004 | J Intern Med2004，255，2： | 1 |
| 9 | High apolipoprotein B,low apolipoprotein A-I,and improvement in the prediction of fatal myocardial infarction (AMORIS Study); a prospective study显示文摘 | Walldius G Junger I Hgolme I | 2001 | Lancet2001，358，12： | 1 |
| 10 | Apolipoprotein B and A1 values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials显示文摘 | Jungner I Marcovina SM Walldius G Holme I Kolar W Steiner E | 1998 | Clin Chem1998，44，8： | 1 |
| 11 | Apolipoprotein B and apolipoprotein A1: risk indicators of coronary heart disease and targets for lipid-modifying therapy 显示文摘 | Walldius G Jungner I | 2004 | J Intern Med2004，255，2： | 1 |
| 12 | The apoB/apoA1 Ratio is better than the cholesterol ratios to estimate the balance between the plasma proatherogenic and anfiatherogenic lipoproteins and predict coronary risk 显示文摘 | Walldius G Jungner I Aastveit AH | 2004 | Clin Chem Lab Med2004，42，12： | 1 |
| 13 | Apolipoprotein B and A-I values in 147 576 Swedish males and females,standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials显示文摘 | Jungner I Marcovina SM Walldius G | 1998 | Clin Chem1998，44，1： | 1 |
| 14 | Is there a better marker ofcardiovascular risk than LDL cholesterol?Apolipoproteins B andA-1:new risk factors and targets for therapy显示文摘 | Walldius G Jungner I | 2007 | Nutr MetabCardiovasc Dis2007，17，8： | 1 |
| 15 | Apolipoprotein B and apolipoprotein A- I : risk indicators of coronary heart disease and targets for lipid- modifying therapy 显示文摘 | Walldius G Jungner I | 2004 | J Intern Med2004，255，2： | 1 |
| 16 | The apoB/apoA - I ratio: a strong,new risk factor tor cardiovascular disease and a target for lipid - lowering therapy - a review of the evi- dence 显示文摘 | Walldius G Jungner I | 2006 | J Intern Ned2006，259，5： | 1 |
| 17 | The apoB/apoA-1ratio is better than the cholesterol ratios to estimate the balancebetween the plasma proatherogenic and antiatherogeniclipoproteins and to predict coronary risk显示文摘 | Walldius G Jungner I Aastveit A H | 2004 | Clin Chem LabMed2004，42，12： | 1 |
| 18 | Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study 显示文摘 | Van Hemelrijck M Walldius G Jungner I | 2011 | Cancer Causes Contr2011，22，7： | 1 |
| 19 | High apolipoprotein B, low apolipoprotein AⅠ, and improvement in the prediction of fatal myocardial infarction(AMORIS Study); a prospective study显示文摘 | Walldius G Junger I Hgolme I | 2001 | Lancet2001，358，12： | 1 |
| 20 | High apolipoprotein B,low apolipoprotein A-I,and improvement in the prediction of fatal myocardial infarction (AMORIS study):a prospective study显示文摘 | WALLDIUS G JUNGNER I HOLME I | | 0，，9298： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员